| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Spread of artemisinin resistance in Plasmodium falciparum malaria.
|
N Engl J Med
|
2014
|
11.87
|
|
2
|
Mixed-species malaria infections in humans.
|
Trends Parasitol
|
2004
|
6.01
|
|
3
|
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
|
PLoS One
|
2009
|
5.81
|
|
4
|
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
|
J Infect Dis
|
2007
|
4.35
|
|
5
|
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally.
|
J Infect Dis
|
2010
|
3.21
|
|
6
|
Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect P. knowlesi.
|
J Clin Microbiol
|
2009
|
2.85
|
|
7
|
Central role of the spleen in malaria parasite clearance.
|
J Infect Dis
|
2002
|
2.80
|
|
8
|
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.
|
Antimicrob Agents Chemother
|
2004
|
2.77
|
|
9
|
Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2010
|
2.68
|
|
10
|
Contrasting genetic structure in Plasmodium vivax populations from Asia and South America.
|
Int J Parasitol
|
2007
|
2.41
|
|
11
|
Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand.
|
Trop Med Int Health
|
2004
|
2.37
|
|
12
|
Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
|
Antimicrob Agents Chemother
|
2003
|
2.26
|
|
13
|
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
|
Malar J
|
2005
|
2.15
|
|
14
|
A systematic overview of published antimalarial drug trials.
|
Trans R Soc Trop Med Hyg
|
2004
|
2.02
|
|
15
|
Spiroindolone KAE609 for falciparum and vivax malaria.
|
N Engl J Med
|
2014
|
1.99
|
|
16
|
Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
|
Antimicrob Agents Chemother
|
2009
|
1.72
|
|
17
|
Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus.
|
J Clin Microbiol
|
2008
|
1.64
|
|
18
|
Rapid diagnosis of scrub typhus in rural Thailand using polymerase chain reaction.
|
Am J Trop Med Hyg
|
2006
|
1.63
|
|
19
|
Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
|
Mol Biochem Parasitol
|
2002
|
1.62
|
|
20
|
Genetic diversity of Plasmodium vivax in Kolkata, India.
|
Malar J
|
2006
|
1.49
|
|
21
|
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
|
PLoS One
|
2010
|
1.48
|
|
22
|
In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
|
Am J Trop Med Hyg
|
2004
|
1.43
|
|
23
|
Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar.
|
Antimicrob Agents Chemother
|
2008
|
1.39
|
|
24
|
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
|
Malar J
|
2010
|
1.35
|
|
25
|
Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
|
Antimicrob Agents Chemother
|
2005
|
1.33
|
|
26
|
Plasmodium vivax adherence to placental glycosaminoglycans.
|
PLoS One
|
2012
|
1.22
|
|
27
|
Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
|
Malar J
|
2010
|
1.22
|
|
28
|
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
|
Crit Care Med
|
2009
|
1.20
|
|
29
|
Serological and blood culture investigations of Nepalese fever patients.
|
Trans R Soc Trop Med Hyg
|
2007
|
1.18
|
|
30
|
Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae.
|
Antimicrob Agents Chemother
|
2007
|
1.10
|
|
31
|
Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria.
|
Antimicrob Agents Chemother
|
2003
|
1.10
|
|
32
|
Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
|
PLoS One
|
2012
|
1.03
|
|
33
|
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
|
Trans R Soc Trop Med Hyg
|
2005
|
1.02
|
|
34
|
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.
|
Malar J
|
2014
|
1.01
|
|
35
|
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
|
Antivir Ther
|
2012
|
0.98
|
|
36
|
Neuropathologic toxicity of artemisinin derivatives in a mouse model.
|
Am J Trop Med Hyg
|
2002
|
0.98
|
|
37
|
Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand.
|
Malar J
|
2013
|
0.97
|
|
38
|
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
|
Malar J
|
2015
|
0.91
|
|
39
|
A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital, Nepal.
|
Southeast Asian J Trop Med Public Health
|
2006
|
0.89
|
|
40
|
Estimating the true accuracy of diagnostic tests for dengue infection using bayesian latent class models.
|
PLoS One
|
2013
|
0.89
|
|
41
|
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
|
Malar J
|
2013
|
0.86
|
|
42
|
Accurate and sensitive detection of Plasmodium species in humans by use of the dihydrofolate reductase-thymidylate synthase linker region.
|
J Clin Microbiol
|
2010
|
0.85
|
|
43
|
Assessment of the neurotoxicity of oral dihydroartemisinin in mice.
|
Trans R Soc Trop Med Hyg
|
2002
|
0.81
|
|
44
|
Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
|
Antimicrob Agents Chemother
|
2013
|
0.79
|
|
45
|
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
|
Antimicrob Agents Chemother
|
2013
|
0.77
|
|
46
|
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
|
Malar J
|
2012
|
0.77
|
|
47
|
Correction: The Diversity and Geographical Structure of Orientia tsutsugamushi Strains from Scrub Typhus Patients in Laos.
|
PLoS Negl Trop Dis
|
2016
|
0.75
|